Literature DB >> 15522483

Concerns for the worse off: fair innings versus severity.

Erik Nord1.   

Abstract

The original fair innings argument is about claims on length of life. Alan Williams has suggested that the argument also should apply to quality of life. His 'generalised fair innings approach' on the one hand, and the severity approach on the other, are two ways of incorporating concerns for fairness in economic evaluation of health care. They are based on different ethical arguments and therefore partly lead to different results. Both approaches incorporate concerns for current and future severity. There is strong support for this in formal theories of justice and government guidelines, and a number of public surveys even indicate the strength of these concerns. The generalised fair innings approach additionally incorporates concerns for past suffering. Intuitively, this is not unreasonable, but there is at this point little ethical theory or empirical evidence to suggest the strength of such concerns. The fair innings argument can be decomposed in an 'equal innings argument' and a 'sufficient innings argument'. When the fair innings argument is applied to quality of life, its sufficient innings component implies that young people should have priority over old people when it comes to functional improvements and symptom relief for non-fatal conditions. This runs counter to both moral intuitions and official goverment guidelines in Norway and Sweden.

Entities:  

Keywords:  Analytical Approach; Health Care and Public Health

Mesh:

Year:  2005        PMID: 15522483     DOI: 10.1016/j.socscimed.2004.05.003

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  20 in total

1.  Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall.

Authors:  Elly A Stolk; Gijs van Donselaar; Werner B F Brouwer; Jan J V Busschbach
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Expensive cancer drugs: a comparison between the United States and the United Kingdom.

Authors:  Ruth R Faden; Kalipso Chalkidou; John Appleby; Hugh R Waters; Jonathon P Leider
Journal:  Milbank Q       Date:  2009-12       Impact factor: 4.911

3.  Are some QALYs more equal than others?

Authors:  E J van de Wetering; N J A van Exel; J M Rose; R J Hoefman; W B F Brouwer
Journal:  Eur J Health Econ       Date:  2014-12-06

4.  Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss.

Authors:  Ulrikke J V Hernæs; Kjell A Johansson; Trygve Ottersen; Ole F Norheim
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

5.  Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall.

Authors:  E J van de Wetering; E A Stolk; N J A van Exel; W B F Brouwer
Journal:  Eur J Health Econ       Date:  2011-08-26

Review 6.  Valuation of health states in the US study to establish disability weights: lessons from the literature.

Authors:  Jürgen Rehm; Ulrich Frick
Journal:  Int J Methods Psychiatr Res       Date:  2010-03       Impact factor: 4.035

7.  Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.

Authors:  Thomas Ward; Ruben E Mujica-Mota; Anne E Spencer; Antonieta Medina-Lara
Journal:  Pharmacoeconomics       Date:  2021-10-29       Impact factor: 4.981

8.  Notions of just health care at three Swedish hospitals.

Authors:  Carl-Ake Elmersjö; Gert Helgesson
Journal:  Med Health Care Philos       Date:  2007-07-05

9.  One and done? Equality of opportunity and repeated access to scarce, indivisible medical resources.

Authors:  Marco D Huesch
Journal:  BMC Med Ethics       Date:  2012-05-24       Impact factor: 2.652

10.  Treatment costs and priority setting in health care: A qualitative study.

Authors:  John McKie; Bradley Shrimpton; Jeff Richardson; Rosalind Hurworth
Journal:  Aust New Zealand Health Policy       Date:  2009-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.